Glenmark Pharmaceuticals Inc., USA: Diltiazem Hydrochloride Extended-Release
Recall reason: cGMP Deviations: Presence of N-nitroso-Desmethyl-Diltiazem impurity above FDA recommended interim limit.. Recalled by Glenmark Pharmaceuticals Inc., USA. Distribution: Nationwide in the USA. Classification (Class II — potential health risk). Affected lots/NDC/dates: Lot #:17222547, Exp. Date, 11/30/2024; 17230598, Exp. Date 02/28/2025. Return the recalled medication to the pharmacy where you purchased it for a full refund of the purchase price.
📬 Get email alerts for new Product Recalls & Refunds
Free — we'll email you when new matching opportunities appear. No spam, unsubscribe anytime.
New here? Here's how Reward Opportunity works:
🔔 More Product Recalls & Refunds
Product recalls offering refunds, replacements, or repairs to consumers who purchased the item.
Browse all product recalls & refunds →Not just this one — find everything you qualify for
Our AI scans 8,000+ bounties, settlements, grants, recalls, and paid studies against your profile to rank what you can actually claim.
Get My Free Match Report